Quantinno Capital Management’s AstraZeneca AZN Stock Holding History

Quantinno Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,000	Closed	-$1.77M	–	3445
2026 Q1	$1.77M	Buy	+9,000	New	+$1.74M	﹤0.01%	1696
2025 Q3	–	Sell	-10,000	Closed	-$1.4M	–	2932
2025 Q2	$1.4M	Buy	+10,000	New	+$1.4M	0.01%	1199

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Quantinno Capital Management's AZN Position: Q2 2026 in Review

Quantinno Capital Management increased its AstraZeneca (AZN) stake by 12% in Q2 2026, buying an estimated $5.51M and bringing the position to 264,383 shares worth $50M. The position accounts for 0.06% of the portfolio, ranked #389.

Quantinno Capital Management first reported a position in AZN in Q2 2022 and has held it in 16 quarters since. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Quantinno Capital Management held 264,383 shares of AstraZeneca worth $50M as of Q2 2026.
Quantinno Capital Management bought 29,289 AstraZeneca shares in Q2 2026, an estimated $5.51M.
AstraZeneca made up 0.06% of Quantinno Capital Management's portfolio in Q2 2026, its #389 holding.
Quantinno Capital Management first reported a position in AstraZeneca in Q2 2022 and has held it in 16 quarters since.
1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.